Australia’s Bionomics To Pay Ironwood Of U.S. To Develop Anxiety Drug
This article was originally published in PharmAsia News
Executive Summary
Bionomics of Australia and Ironwood Pharmaceuticals of the U.S. have agreed to a hand-off of a drug to treat anxiety, with Bionomics paying Ironwood in a deal worth as much as.$353 million.